Akoya Biosciences, Inc. (AKYA)
USD 2.45
(-3.54%)
USD 2.45
(-3.54%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 96.63 Million | 74.85 Million | 54.91 Million | 42.44 Million | 42.23 Million |
| Cost of Revenue | 40.32 Million | 31.46 Million | 20.69 Million | 16.53 Million | 17.57 Million |
| Gross Profit | 56.3 Million | 43.39 Million | 34.21 Million | 25.9 Million | 24.66 Million |
| Operating Expenses | 104.27 Million | 109.59 Million | 71.44 Million | 37.4 Million | 38.16 Million |
| Selling, General and Administrative Expenses | 82.38 Million | 79.65 Million | 51.01 Million | 23.98 Million | 26.35 Million |
| Research and Development Expenses | 21.88 Million | 23.21 Million | 15.7 Million | 9.6 Million | 8.76 Million |
| Other Expenses | 9.7 Million | 6.73 Million | 4.72 Million | 3.81 Million | 3.05 Million |
| Cost and Expenses | 154.3 Million | 141.06 Million | 92.14 Million | 53.93 Million | 55.74 Million |
| Operating Income | -57.66 Million | -66.2 Million | -37.22 Million | -11.49 Million | -13.5 Million |
| Interest Expense | 8.76 Million | 4.55 Million | 3.11 Million | 2.72 Million | 1.88 Million |
| Income Tax Expense | 40 Thousand | 123 Thousand | -140 Thousand | 42 Thousand | 194 Thousand |
| Earnings before Tax | -63.28 Million | -70.51 Million | -43.07 Million | -16.66 Million | -14.55 Million |
| Net Income | -63.32 Million | -70.64 Million | -42.93 Million | -16.7 Million | -14.75 Million |
| Earnings Per Share Basic | -1.43 | -1.87 | -1.15 | -0.45 | -0.40 |
| Earnings Per Share Diluted | -1.43 | -1.87 | -1.15 | -0.45 | -0.40 |
| Weighted Average Shares Outstanding | 44.43 Million | 37.74 Million | 37.42 Million | 37.11 Million | 37.11 Million |
| Weighted Average Shares Outstanding (Diluted) | 44.43 Million | 37.74 Million | 37.42 Million | 37.11 Million | 37.11 Million |
| Gross Margin | 0.58 | 0.58 | 0.62 | 0.61 | 0.58 |
| EBIT Margin | -0.47 | -0.79 | -0.60 | -0.18 | -0.26 |
| Profit Margin | -0.66 | -0.94 | -0.78 | -0.39 | -0.35 |
| EBITDA | -45.63 Million | -58.81 Million | -35.16 Million | -10.12 Million | -9.62 Million |
| Earnings Before Tax Margin | -0.60 | -0.88 | -0.68 | -0.27 | -0.32 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 23.16 Million | 18.35 Million | 26.48 Million | 96.63 Million | 25.21 Million | 23.52 Million |
| Cost of Revenue | 9.77 Million | 9.97 Million | 11.74 Million | 48.39 Million | 9.93 Million | 11.4 Million |
| Gross Profit | 13.38 Million | 8.37 Million | 14.74 Million | 48.23 Million | 15.27 Million | 12.11 Million |
| Operating Expenses | 24.38 Million | 25.41 Million | 23.56 Million | 104.27 Million | 24.19 Million | 30.82 Million |
| Selling, General and Administrative Expenses | 19.09 Million | 19.86 Million | 18.89 Million | - | 19.01 Million | 22.7 Million |
| Research and Development Expenses | 5.28 Million | 5.55 Million | 4.67 Million | - | 5.17 Million | 6.27 Million |
| Other Expenses | -80 Thousand | -161 Thousand | -5000.00 | -343 Thousand | -185 Thousand | -105 Thousand |
| Cost and Expenses | 34.16 Million | 35.38 Million | 35.3 Million | 152.66 Million | 34.12 Million | 42.23 Million |
| Operating Income | -10.99 Million | -17.03 Million | -8.82 Million | -56.03 Million | -11.55 Million | -19.24 Million |
| Interest Expense | 2.6 Million | 2.61 Million | 2.29 Million | 8.76 Million | -2.23 Million | 2.17 Million |
| Income Tax Expense | 47 Thousand | 63 Thousand | -22 Thousand | 40 Thousand | -15 Thousand | 18 Thousand |
| Earnings before Tax | -13.1 Million | -23.42 Million | -10.82 Million | -63.28 Million | -12.9 Million | -20.78 Million |
| Net Income | -13.14 Million | -23.48 Million | -10.8 Million | -63.32 Million | -12.91 Million | -20.8 Million |
| Earnings Per Share Basic | -0.27 | -0.48 | -0.22 | - | -0.26 | -0.51 |
| Earnings Per Share Diluted | -0.27 | -0.48 | -0.22 | - | -0.26 | -0.51 |
| Weighted Average Shares Outstanding | 49.41 Million | 49.18 Million | 49.08 Million | 44.43 Million | 48.97 Million | 40.63 Million |
| Weighted Average Shares Outstanding (Diluted) | 49.41 Million | 49.18 Million | 49.08 Million | 44.43 Million | 48.97 Million | 40.63 Million |
| Gross Margin | 0.58 | 0.46 | 0.56 | 0.50 | 0.61 | 0.52 |
| EBIT Margin | -0.39 | -0.82 | -0.25 | - | -0.51 | -0.69 |
| Profit Margin | -0.57 | -1.28 | -0.41 | -0.66 | -0.51 | -0.88 |
| EBITDA | -9.07 Million | -14.98 Million | -6.71 Million | - | -12.79 Million | -16.23 Million |
| Earnings Before Tax Margin | -0.47 | -0.93 | -0.33 | -0.58 | -0.46 | -0.82 |
PVW
CBG-R
MFA-PB
AX8
HEHSF
000240